These compounds also led to a dose-dependent reduction in cell viability of melanoma cells with IC50 values close to 10 μM, which suggests that interfering with the DNA repair and epigenetic activity of TDG may represent a new and valid approach for the treatment of melanoma. Here, TDG is linked to melanoma.